

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 9.73428597 |
| 2 | fibril organization (GO:0097435) | 9.52730167 |
| 3 | glutathione derivative biosynthetic process (GO:1901687) | 8.81792228 |
| 4 | glutathione derivative metabolic process (GO:1901685) | 8.81792228 |
| 5 | O-glycan processing (GO:0016266) | 8.67638798 |
| 6 | response to iron ion (GO:0010039) | 8.66813674 |
| 7 | neutral lipid catabolic process (GO:0046461) | 8.64207712 |
| 8 | acylglycerol catabolic process (GO:0046464) | 8.64207712 |
| 9 | * digestion (GO:0007586) | 8.56291745 |
| 10 | digestive system process (GO:0022600) | 8.26419514 |
| 11 | biotin metabolic process (GO:0006768) | 8.17056496 |
| 12 | sulfation (GO:0051923) | 7.92869939 |
| 13 | protein autoprocessing (GO:0016540) | 7.78174149 |
| 14 | lipid storage (GO:0019915) | 7.72486127 |
| 15 | fatty acid homeostasis (GO:0055089) | 7.52694163 |
| 16 | lipid particle organization (GO:0034389) | 7.27114486 |
| 17 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.14917229 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 6.98719425 |
| 19 | glandular epithelial cell differentiation (GO:0002067) | 6.88960794 |
| 20 | cellular response to cadmium ion (GO:0071276) | 6.78361176 |
| 21 | negative regulation of digestive system process (GO:0060457) | 6.69667288 |
| 22 | kidney morphogenesis (GO:0060993) | 6.48825220 |
| 23 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 6.32956979 |
| 24 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 6.32956979 |
| 25 | positive regulation of lipid storage (GO:0010884) | 6.16584024 |
| 26 | protein O-linked glycosylation (GO:0006493) | 6.16324805 |
| 27 | glycerolipid catabolic process (GO:0046503) | 6.15716895 |
| 28 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 6.15706425 |
| 29 | regulation of proton transport (GO:0010155) | 6.09357258 |
| 30 | triglyceride metabolic process (GO:0006641) | 5.94562948 |
| 31 | CDP-diacylglycerol metabolic process (GO:0046341) | 5.93914410 |
| 32 | triglyceride biosynthetic process (GO:0019432) | 5.92658435 |
| 33 | production of molecular mediator of immune response (GO:0002440) | 5.78654032 |
| 34 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.78407361 |
| 35 | acylglycerol biosynthetic process (GO:0046463) | 5.65552571 |
| 36 | neutral lipid biosynthetic process (GO:0046460) | 5.65552571 |
| 37 | acylglycerol metabolic process (GO:0006639) | 5.56728950 |
| 38 | neutral lipid metabolic process (GO:0006638) | 5.49274230 |
| 39 | L-fucose catabolic process (GO:0042355) | 5.30468818 |
| 40 | fucose catabolic process (GO:0019317) | 5.30468818 |
| 41 | L-fucose metabolic process (GO:0042354) | 5.30468818 |
| 42 | intestinal absorption (GO:0050892) | 5.13519084 |
| 43 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.13164878 |
| 44 | positive regulation of triglyceride metabolic process (GO:0090208) | 5.09901015 |
| 45 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.07969357 |
| 46 | oxaloacetate metabolic process (GO:0006107) | 4.94676258 |
| 47 | regulation of lipid storage (GO:0010883) | 4.93371839 |
| 48 | negative regulation of lipid catabolic process (GO:0050995) | 4.90612915 |
| 49 | thyroid hormone metabolic process (GO:0042403) | 4.83484868 |
| 50 | thioester biosynthetic process (GO:0035384) | 4.82957347 |
| 51 | acyl-CoA biosynthetic process (GO:0071616) | 4.82957347 |
| 52 | sulfur amino acid catabolic process (GO:0000098) | 4.74181091 |
| 53 | protein heterotrimerization (GO:0070208) | 4.68435208 |
| 54 | negative regulation of lipid storage (GO:0010888) | 4.64017268 |
| 55 | glutathione metabolic process (GO:0006749) | 4.62947641 |
| 56 | carnitine shuttle (GO:0006853) | 4.52153666 |
| 57 | white fat cell differentiation (GO:0050872) | 4.49146480 |
| 58 | response to phenylpropanoid (GO:0080184) | 4.48369586 |
| 59 | thyroid hormone generation (GO:0006590) | 4.47297288 |
| 60 | positive regulation of lipid catabolic process (GO:0050996) | 4.46914467 |
| 61 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.45712714 |
| 62 | phospholipid scrambling (GO:0017121) | 4.39988514 |
| 63 | NADH metabolic process (GO:0006734) | 4.31782661 |
| 64 | regulation of lipid catabolic process (GO:0050994) | 4.16862013 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.10688221 |
| 66 | acetyl-CoA metabolic process (GO:0006084) | 4.03643449 |
| 67 | xenobiotic metabolic process (GO:0006805) | 4.03611784 |
| 68 | fatty acid transmembrane transport (GO:1902001) | 4.01092387 |
| 69 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.00026231 |
| 70 | phosphatidic acid metabolic process (GO:0046473) | 3.94218069 |
| 71 | phosphatidic acid biosynthetic process (GO:0006654) | 3.94218069 |
| 72 | nitric oxide biosynthetic process (GO:0006809) | 3.93253602 |
| 73 | ovulation cycle (GO:0042698) | 3.92790529 |
| 74 | response to dietary excess (GO:0002021) | 3.90630470 |
| 75 | valine metabolic process (GO:0006573) | 3.87757637 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.85934527 |
| 77 | receptor recycling (GO:0001881) | 3.84585993 |
| 78 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.82006701 |
| 79 | lung secretory cell differentiation (GO:0061140) | 3.81298267 |
| 80 | skeletal muscle organ development (GO:0060538) | 3.79672218 |
| 81 | brown fat cell differentiation (GO:0050873) | 3.76912570 |
| 82 | regulation of execution phase of apoptosis (GO:1900117) | 3.75411716 |
| 83 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.74527015 |
| 84 | regulation of triglyceride metabolic process (GO:0090207) | 3.67862586 |
| 85 | regulation of pH (GO:0006885) | 3.66024380 |
| 86 | alanine transport (GO:0032328) | 3.65629362 |
| 87 | negative regulation of granulocyte differentiation (GO:0030853) | 3.63802442 |
| 88 | positive regulation of glomerulus development (GO:0090193) | 3.60764469 |
| 89 | cellular response to gonadotropin stimulus (GO:0071371) | 3.58347324 |
| 90 | regulation of phospholipase A2 activity (GO:0032429) | 3.57801141 |
| 91 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.54610673 |
| 92 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.48722533 |
| 93 | cyclooxygenase pathway (GO:0019371) | 3.48688924 |
| 94 | atrioventricular valve morphogenesis (GO:0003181) | 3.48608816 |
| 95 | cellular response to arsenic-containing substance (GO:0071243) | 3.47791945 |
| 96 | response to zinc ion (GO:0010043) | 3.46766502 |
| 97 | phosphatidylserine metabolic process (GO:0006658) | 3.46633342 |
| 98 | removal of superoxide radicals (GO:0019430) | 3.45463384 |
| 99 | cellular response to superoxide (GO:0071451) | 3.45463384 |
| 100 | cellular response to oxygen radical (GO:0071450) | 3.45463384 |
| 101 | positive regulation of p38MAPK cascade (GO:1900745) | 3.44432876 |
| 102 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.41509020 |
| 103 | positive regulation of urine volume (GO:0035810) | 3.41483065 |
| 104 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.37322790 |
| 105 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.36671932 |
| 106 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.34834211 |
| 107 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 3.34377797 |
| 108 | retinol metabolic process (GO:0042572) | 3.32965135 |
| 109 | acrosome reaction (GO:0007340) | 3.32570546 |
| 110 | embryonic foregut morphogenesis (GO:0048617) | 3.32424975 |
| 111 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.32344468 |
| 112 | leukotriene metabolic process (GO:0006691) | 3.32195515 |
| 113 | positive regulation of fatty acid oxidation (GO:0046321) | 3.31879781 |
| 114 | diacylglycerol metabolic process (GO:0046339) | 3.31718250 |
| 115 | growth hormone receptor signaling pathway (GO:0060396) | 3.30822249 |
| 116 | positive regulation of metanephros development (GO:0072216) | 3.30089289 |
| 117 | acyl-CoA metabolic process (GO:0006637) | 3.26726340 |
| 118 | thioester metabolic process (GO:0035383) | 3.26726340 |
| 119 | intestinal epithelial cell development (GO:0060576) | 3.26110497 |
| 120 | trophoblast giant cell differentiation (GO:0060707) | 3.25148108 |
| 121 | ovulation from ovarian follicle (GO:0001542) | 3.24420820 |
| 122 | negative regulation of protein autophosphorylation (GO:0031953) | 3.24410163 |
| 123 | primary alcohol metabolic process (GO:0034308) | 3.23195336 |
| 124 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.22620501 |
| 125 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.22408275 |
| 126 | carnitine transmembrane transport (GO:1902603) | 3.22300633 |
| 127 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.22087715 |
| 128 | coenzyme A biosynthetic process (GO:0015937) | 3.21822716 |
| 129 | regulation of cardioblast differentiation (GO:0051890) | 3.18317509 |
| 130 | vitamin transmembrane transport (GO:0035461) | 3.17713261 |
| 131 | L-serine transport (GO:0015825) | 3.17296063 |
| 132 | tricarboxylic acid metabolic process (GO:0072350) | 3.16793574 |
| 133 | response to hydroperoxide (GO:0033194) | 3.15881830 |
| 134 | negative regulation of norepinephrine secretion (GO:0010700) | 3.14752857 |
| 135 | regulation of macrophage activation (GO:0043030) | 3.12821586 |
| 136 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.10337094 |
| 137 | acylglycerol homeostasis (GO:0055090) | 3.09635580 |
| 138 | triglyceride homeostasis (GO:0070328) | 3.09635580 |
| 139 | ethanol oxidation (GO:0006069) | 3.05325466 |
| 140 | regulation of cholesterol storage (GO:0010885) | 3.05318339 |
| 141 | response to superoxide (GO:0000303) | 3.03915431 |
| 142 | positive regulation of cholesterol efflux (GO:0010875) | 3.03692440 |
| 143 | negative regulation of macrophage differentiation (GO:0045650) | 3.03608100 |
| 144 | ethanol metabolic process (GO:0006067) | 3.03243794 |
| 145 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.03100244 |
| 146 | cell communication involved in cardiac conduction (GO:0086065) | 3.02008563 |
| 147 | fucose metabolic process (GO:0006004) | 2.99008931 |
| 148 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.98261425 |
| 149 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.98261425 |
| 150 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.98261425 |
| 151 | protein retention in ER lumen (GO:0006621) | 2.96551547 |
| 152 | cAMP biosynthetic process (GO:0006171) | 2.91603034 |
| 153 | regulation of p38MAPK cascade (GO:1900744) | 2.91551904 |
| 154 | negative regulation of platelet activation (GO:0010544) | 2.90022357 |
| 155 | temperature homeostasis (GO:0001659) | 2.89362238 |
| 156 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.89328928 |
| 157 | sodium ion export (GO:0071436) | 2.88827991 |
| 158 | alditol phosphate metabolic process (GO:0052646) | 2.87348075 |
| 159 | cardiac conduction (GO:0061337) | 2.85240499 |
| 160 | desmosome organization (GO:0002934) | 2.85101939 |
| 161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.83040736 |
| 162 | response to oxygen radical (GO:0000305) | 2.82552474 |
| 163 | pH reduction (GO:0045851) | 2.81045155 |
| 164 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.80557935 |
| 165 | flavonoid metabolic process (GO:0009812) | 2.79400025 |
| 166 | peptidyl-proline hydroxylation (GO:0019511) | 2.79199625 |
| 167 | serine transport (GO:0032329) | 2.73079012 |
| 168 | leukotriene biosynthetic process (GO:0019370) | 2.72766706 |
| 169 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.71584949 |
| 170 | acid secretion (GO:0046717) | 2.69820963 |
| 171 | hexose catabolic process (GO:0019320) | 2.68234691 |
| 172 | hepatocyte apoptotic process (GO:0097284) | 2.67983613 |
| 173 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.67919539 |
| 174 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.66145667 |
| 175 | epithelial cell-cell adhesion (GO:0090136) | 2.65833650 |
| 176 | response to gonadotropin (GO:0034698) | 2.65426481 |
| 177 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.65240316 |
| 178 | regulation of skeletal muscle contraction (GO:0014819) | 2.64811272 |
| 179 | cellular glucuronidation (GO:0052695) | 2.58546472 |
| 180 | hormone catabolic process (GO:0042447) | 2.58235578 |
| 181 | GDP-mannose metabolic process (GO:0019673) | 2.57892357 |
| 182 | xenobiotic catabolic process (GO:0042178) | 2.57777158 |
| 183 | negative regulation of cholesterol transport (GO:0032375) | 2.45450780 |
| 184 | negative regulation of sterol transport (GO:0032372) | 2.45450780 |
| 185 | synaptic transmission, cholinergic (GO:0007271) | 2.44816270 |
| 186 | monovalent inorganic cation homeostasis (GO:0055067) | 2.43413512 |
| 187 | endocardial cushion development (GO:0003197) | 2.42603761 |
| 188 | uronic acid metabolic process (GO:0006063) | 2.42377021 |
| 189 | glucuronate metabolic process (GO:0019585) | 2.42377021 |
| 190 | maintenance of gastrointestinal epithelium (GO:0030277) | 19.3264725 |
| 191 | epithelial structure maintenance (GO:0010669) | 14.5198433 |
| 192 | regulation of sequestering of triglyceride (GO:0010889) | 13.0535681 |
| 193 | extracellular fibril organization (GO:0043206) | 11.0829720 |
| 194 | cellular response to zinc ion (GO:0071294) | 10.6634878 |
| 195 | low-density lipoprotein particle clearance (GO:0034383) | 10.5618890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 7.64109140 |
| 2 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 5.76202775 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.88138574 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.36503789 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.31380017 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.96760471 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.86809733 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.38048210 |
| 9 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.01500556 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.99404594 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.70552059 |
| 12 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.63007986 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61337534 |
| 14 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.58766908 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.50139524 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.48512718 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.46467370 |
| 18 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.46204182 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.38029792 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34535293 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.25952186 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.23895552 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17991647 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.15746824 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05391972 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.02129027 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.99044471 |
| 28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.95587275 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.91914364 |
| 30 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.91130025 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86676365 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.86203177 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82812689 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80907740 |
| 35 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.78072745 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76277449 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75599988 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66253528 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.63317144 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61089103 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60813499 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.58068450 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.58068450 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.58068450 |
| 45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.56807506 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56415194 |
| 47 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.56166283 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55942542 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53230814 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51842177 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50291536 |
| 52 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48988072 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48689087 |
| 54 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.48585115 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48448283 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47304193 |
| 57 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45953017 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44672447 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44504507 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.43979389 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42902636 |
| 62 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41986981 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40031363 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39627172 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38453368 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33734973 |
| 67 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.32944355 |
| 68 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.31113707 |
| 69 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.30741352 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30282182 |
| 71 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.30134656 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28410612 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25951565 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21276642 |
| 75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20551888 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19820122 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19123531 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18600573 |
| 79 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18552342 |
| 80 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18552342 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18484020 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17939629 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16612396 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16123139 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15378359 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15256491 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15220189 |
| 88 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13237122 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13118439 |
| 90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12897744 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10307509 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09973069 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08924619 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08808327 |
| 95 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07981924 |
| 96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06948738 |
| 97 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05852476 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03210897 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02861005 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02830173 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01204472 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99259192 |
| 103 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.99163165 |
| 104 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98910313 |
| 105 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98851664 |
| 106 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98522765 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96450045 |
| 108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95159171 |
| 109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95074136 |
| 110 | CBP_21632823_ChIP-Seq_H3396_Human | 0.94871502 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94564262 |
| 112 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.94186047 |
| 113 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93875705 |
| 114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93129477 |
| 115 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92850310 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92299887 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91315373 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90292775 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90103818 |
| 120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90055789 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89048226 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88713109 |
| 123 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.88443619 |
| 124 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.88443619 |
| 125 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.88084064 |
| 126 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.86720095 |
| 127 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86304874 |
| 128 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85079123 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83993684 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83820082 |
| 131 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83564202 |
| 132 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83546693 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83433696 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83302664 |
| 135 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.83246402 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83154862 |
| 137 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83151177 |
| 138 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82866336 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82866336 |
| 140 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82583021 |
| 141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80113351 |
| 142 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.80067923 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79765160 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78606513 |
| 145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78606513 |
| 146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78166541 |
| 147 | P68_20966046_ChIP-Seq_HELA_Human | 0.77958922 |
| 148 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77549525 |
| 149 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77077173 |
| 150 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.75557312 |
| 151 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.75078791 |
| 152 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75003848 |
| 153 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74533455 |
| 154 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.74292185 |
| 155 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74269926 |
| 156 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73486881 |
| 157 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.73451854 |
| 158 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73144218 |
| 159 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71164214 |
| 160 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.71061033 |
| 161 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70349817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.15724239 |
| 2 | MP0001873_stomach_inflammation | 6.33658500 |
| 3 | MP0005666_abnormal_adipose_tissue | 5.61982691 |
| 4 | MP0002971_abnormal_brown_adipose | 5.29219037 |
| 5 | MP0001664_abnormal_digestion | 5.10489149 |
| 6 | MP0000470_abnormal_stomach_morphology | 3.81944421 |
| 7 | MP0005375_adipose_tissue_phenotype | 3.74255692 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.57011420 |
| 9 | MP0005535_abnormal_body_temperature | 3.13753452 |
| 10 | MP0006138_congestive_heart_failure | 3.10622902 |
| 11 | MP0005334_abnormal_fat_pad | 3.02079891 |
| 12 | MP0009115_abnormal_fat_cell | 2.48350271 |
| 13 | MP0000343_altered_response_to | 2.24129658 |
| 14 | MP0001663_abnormal_digestive_system | 2.22511569 |
| 15 | MP0003959_abnormal_lean_body | 2.18464636 |
| 16 | MP0005448_abnormal_energy_balance | 2.06272254 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.02233874 |
| 18 | MP0008004_abnormal_stomach_pH | 17.4430280 |
| 19 | MP0005381_digestive/alimentary_phenotyp | 1.93936438 |
| 20 | MP0003828_pulmonary_edema | 1.93354932 |
| 21 | MP0002295_abnormal_pulmonary_circulatio | 1.90744382 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.86594523 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 1.84799702 |
| 24 | MP0005452_abnormal_adipose_tissue | 1.84663006 |
| 25 | MP0005165_increased_susceptibility_to | 1.73309343 |
| 26 | MP0005647_abnormal_sex_gland | 1.73072032 |
| 27 | MP0001661_extended_life_span | 1.67459060 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.63703656 |
| 29 | MP0003303_peritoneal_inflammation | 1.61747460 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.46501359 |
| 31 | MP0000003_abnormal_adipose_tissue | 1.45742550 |
| 32 | MP0002254_reproductive_system_inflammat | 1.44965836 |
| 33 | MP0000751_myopathy | 1.41971524 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.37564187 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.34144470 |
| 36 | MP0003948_abnormal_gas_homeostasis | 1.33833532 |
| 37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.32892613 |
| 38 | MP0009278_abnormal_bone_marrow | 1.30675214 |
| 39 | MP0000477_abnormal_intestine_morphology | 1.30005401 |
| 40 | MP0005595_abnormal_vascular_smooth | 1.28754351 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.27699916 |
| 42 | MP0005083_abnormal_biliary_tract | 1.22938068 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.18272711 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.17581685 |
| 45 | MP0003283_abnormal_digestive_organ | 1.16659289 |
| 46 | MP0001727_abnormal_embryo_implantation | 1.16147607 |
| 47 | MP0005164_abnormal_response_to | 1.11796679 |
| 48 | MP0003186_abnormal_redox_activity | 1.10711777 |
| 49 | MP0006054_spinal_hemorrhage | 1.09991408 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.06675504 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.04643175 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.04421444 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.04421444 |
| 54 | MP0005385_cardiovascular_system_phenoty | 1.02108587 |
| 55 | MP0001544_abnormal_cardiovascular_syste | 1.02108587 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.99491219 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 0.98787159 |
| 58 | MP0003011_delayed_dark_adaptation | 0.97600258 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 0.97252624 |
| 60 | MP0000249_abnormal_blood_vessel | 0.95851739 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.94432676 |
| 62 | MP0000462_abnormal_digestive_system | 0.92273360 |
| 63 | MP0009672_abnormal_birth_weight | 0.88377638 |
| 64 | MP0001764_abnormal_homeostasis | 0.85595463 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 0.82759331 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.82576326 |
| 67 | MP0009384_cardiac_valve_regurgitation | 0.80584089 |
| 68 | MP0000490_abnormal_crypts_of | 0.79146573 |
| 69 | MP0005365_abnormal_bile_salt | 0.78143426 |
| 70 | MP0001944_abnormal_pancreas_morphology | 0.77662120 |
| 71 | MP0000767_abnormal_smooth_muscle | 0.77306758 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.73633765 |
| 73 | MP0000537_abnormal_urethra_morphology | 0.72561125 |
| 74 | MP0001542_abnormal_bone_strength | 0.72169667 |
| 75 | MP0001881_abnormal_mammary_gland | 0.71600422 |
| 76 | MP0004510_myositis | 0.70432607 |
| 77 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70283570 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.69978450 |
| 79 | MP0005266_abnormal_metabolism | 0.68016699 |
| 80 | MP0004858_abnormal_nervous_system | 0.66955731 |
| 81 | MP0002972_abnormal_cardiac_muscle | 0.65558688 |
| 82 | MP0004087_abnormal_muscle_fiber | 0.64832820 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.63913860 |
| 84 | MP0002234_abnormal_pharynx_morphology | 0.63315851 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.62818417 |
| 86 | MP0004484_altered_response_of | 0.61705405 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.59742834 |
| 88 | MP0005409_darkened_coat_color | 0.59508408 |
| 89 | MP0003879_abnormal_hair_cell | 0.58308890 |
| 90 | MP0003279_aneurysm | 0.58028689 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.57958911 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.57891643 |
| 93 | MP0010329_abnormal_lipoprotein_level | 0.57482934 |
| 94 | MP0000759_abnormal_skeletal_muscle | 0.57427827 |
| 95 | MP0010630_abnormal_cardiac_muscle | 0.56143344 |
| 96 | MP0003950_abnormal_plasma_membrane | 0.55926115 |
| 97 | MP0002796_impaired_skin_barrier | 0.54850683 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.54451596 |
| 99 | MP0002128_abnormal_blood_circulation | 0.53988889 |
| 100 | MP0003448_altered_tumor_morphology | 0.53690226 |
| 101 | MP0003075_altered_response_to | 0.53174999 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.52969321 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.51583621 |
| 104 | MP0009840_abnormal_foam_cell | 0.50564487 |
| 105 | MP0000858_altered_metastatic_potential | 0.50290844 |
| 106 | MP0009703_decreased_birth_body | 0.49472873 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.48996074 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.48747794 |
| 109 | MP0001243_abnormal_dermal_layer | 0.47637031 |
| 110 | MP0004947_skin_inflammation | 0.46328330 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.44881091 |
| 112 | MP0003868_abnormal_feces_composition | 0.43759001 |
| 113 | MP0002009_preneoplasia | 0.43717288 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.39711612 |
| 115 | MP0003329_amyloid_beta_deposits | 0.39698331 |
| 116 | MP0008873_increased_physiological_sensi | 0.39193062 |
| 117 | MP0003866_abnormal_defecation | 0.39095494 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.36932083 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.36855740 |
| 120 | MP0003119_abnormal_digestive_system | 0.36120787 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.35638416 |
| 122 | MP0005166_decreased_susceptibility_to | 0.35582667 |
| 123 | MP0001849_ear_inflammation | 0.35480208 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 0.35438650 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.35361333 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.34593422 |
| 127 | MP0003953_abnormal_hormone_level | 0.34425170 |
| 128 | MP0002060_abnormal_skin_morphology | 0.34120442 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.33696107 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33361910 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.32489547 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.31281401 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.30937709 |
| 134 | MP0003724_increased_susceptibility_to | 0.30909845 |
| 135 | MP0003252_abnormal_bile_duct | 0.29376449 |
| 136 | MP0000609_abnormal_liver_physiology | 0.29292209 |
| 137 | MP0003638_abnormal_response/metabolism_ | 0.28216010 |
| 138 | MP0005408_hypopigmentation | 0.25796248 |
| 139 | MP0000367_abnormal_coat/_hair | 0.24921558 |
| 140 | MP0005275_abnormal_skin_tensile | 0.24739566 |
| 141 | MP0005501_abnormal_skin_physiology | 0.24399431 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.24196749 |
| 143 | MP0000598_abnormal_liver_morphology | 0.24148909 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.22689969 |
| 145 | MP0004272_abnormal_basement_membrane | 0.22547429 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.22302496 |
| 147 | MP0008961_abnormal_basal_metabolism | 0.21838024 |
| 148 | MP0002970_abnormal_white_adipose | 0.21327426 |
| 149 | MP0000604_amyloidosis | 0.20869407 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.20540039 |
| 151 | MP0004043_abnormal_pH_regulation | 0.19858973 |
| 152 | MP0000013_abnormal_adipose_tissue | 0.19746281 |
| 153 | MP0010771_integument_phenotype | 0.19415119 |
| 154 | MP0005332_abnormal_amino_acid | 0.19002754 |
| 155 | MP0005360_urolithiasis | 0.18451496 |
| 156 | MP0004130_abnormal_muscle_cell | 0.18195801 |
| 157 | MP0005310_abnormal_salivary_gland | 0.17906380 |
| 158 | MP0009053_abnormal_anal_canal | 0.16792481 |
| 159 | MP0009931_abnormal_skin_appearance | 0.16173344 |
| 160 | MP0004859_abnormal_synaptic_plasticity | 0.15531792 |
| 161 | MP0005076_abnormal_cell_differentiation | 0.15488007 |
| 162 | MP0001191_abnormal_skin_condition | 0.15469313 |
| 163 | MP0002098_abnormal_vibrissa_morphology | 0.15250921 |
| 164 | MP0004019_abnormal_vitamin_homeostasis | 0.14811931 |
| 165 | MP0009643_abnormal_urine_homeostasis | 0.14565901 |
| 166 | MP0005367_renal/urinary_system_phenotyp | 0.14033193 |
| 167 | MP0000516_abnormal_urinary_system | 0.14033193 |
| 168 | MP0003690_abnormal_glial_cell | 0.13384164 |
| 169 | MP0000465_gastrointestinal_hemorrhage | 0.13332999 |
| 170 | MP0003656_abnormal_erythrocyte_physiolo | 0.12978060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertriglyceridemia (HP:0002155) | 9.31565276 |
| 2 | Acanthosis nigricans (HP:0000956) | 8.17270603 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 7.97505799 |
| 4 | Difficulty running (HP:0009046) | 7.77458220 |
| 5 | Long foot (HP:0001833) | 7.58365076 |
| 6 | Oligomenorrhea (HP:0000876) | 7.21496613 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.13858941 |
| 8 | Insulin-resistant diabetes mellitus (HP:0000831) | 6.04000758 |
| 9 | Insulin resistance (HP:0000855) | 5.75720910 |
| 10 | Increased muscle lipid content (HP:0009058) | 5.26653213 |
| 11 | Palpitations (HP:0001962) | 4.71414831 |
| 12 | Bone cyst (HP:0012062) | 4.70600139 |
| 13 | Polyphagia (HP:0002591) | 4.64645775 |
| 14 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.59892265 |
| 15 | Abnormality of alanine metabolism (HP:0010916) | 4.59892265 |
| 16 | Hyperalaninemia (HP:0003348) | 4.59892265 |
| 17 | Increased serum pyruvate (HP:0003542) | 4.52084303 |
| 18 | Woolly hair (HP:0002224) | 4.37684273 |
| 19 | Goiter (HP:0000853) | 4.24109231 |
| 20 | Syncope (HP:0001279) | 4.20941654 |
| 21 | Abnormality of glycolysis (HP:0004366) | 4.17240518 |
| 22 | Easy fatigability (HP:0003388) | 3.97667625 |
| 23 | Complement deficiency (HP:0004431) | 3.96147631 |
| 24 | Gout (HP:0001997) | 3.85457018 |
| 25 | Prominent supraorbital ridges (HP:0000336) | 3.83408238 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 3.83237992 |
| 27 | Megaloblastic anemia (HP:0001889) | 3.75776981 |
| 28 | Epidermoid cyst (HP:0200040) | 3.72888599 |
| 29 | Abnormality of complement system (HP:0005339) | 3.65142995 |
| 30 | Neck muscle weakness (HP:0000467) | 3.58661013 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.57746500 |
| 32 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.51332339 |
| 33 | Myocardial infarction (HP:0001658) | 3.49963448 |
| 34 | Back pain (HP:0003418) | 3.45434406 |
| 35 | Large hands (HP:0001176) | 3.36245056 |
| 36 | Abnormality of vitamin B metabolism (HP:0004340) | 3.31268069 |
| 37 | Frequent falls (HP:0002359) | 3.29721462 |
| 38 | Clitoromegaly (HP:0000057) | 3.25946145 |
| 39 | Abnormality of vitamin metabolism (HP:0100508) | 3.21283327 |
| 40 | Protrusio acetabuli (HP:0003179) | 3.15320227 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 3.14121331 |
| 42 | Arterial tortuosity (HP:0005116) | 3.10990332 |
| 43 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.08915513 |
| 44 | Lymphangioma (HP:0100764) | 3.07444773 |
| 45 | Ventricular fibrillation (HP:0001663) | 3.07085921 |
| 46 | Flat acetabular roof (HP:0003180) | 3.00831805 |
| 47 | Hemiplegia (HP:0002301) | 2.98703512 |
| 48 | Glomerulosclerosis (HP:0000096) | 2.94904358 |
| 49 | Ventricular arrhythmia (HP:0004308) | 2.94304173 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.92387035 |
| 51 | Metaphyseal dysplasia (HP:0100255) | 2.91105547 |
| 52 | Skin nodule (HP:0200036) | 2.87340052 |
| 53 | Ventricular tachycardia (HP:0004756) | 2.84778628 |
| 54 | Abnormality of the periventricular white matter (HP:0002518) | 2.82442932 |
| 55 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.74268193 |
| 56 | Accelerated skeletal maturation (HP:0005616) | 2.74260953 |
| 57 | Vascular tortuosity (HP:0004948) | 2.73822622 |
| 58 | Nausea (HP:0002018) | 2.70530446 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.70212041 |
| 60 | Micronodular cirrhosis (HP:0001413) | 2.66648592 |
| 61 | Agitation (HP:0000713) | 2.65638202 |
| 62 | Deep venous thrombosis (HP:0002625) | 2.55213330 |
| 63 | Axonal loss (HP:0003447) | 2.55007936 |
| 64 | Gowers sign (HP:0003391) | 2.51863325 |
| 65 | Increased purine levels (HP:0004368) | 2.47432538 |
| 66 | Hyperuricemia (HP:0002149) | 2.47432538 |
| 67 | Atrophic scars (HP:0001075) | 2.46183098 |
| 68 | Abnormality of the gastric mucosa (HP:0004295) | 2.45277376 |
| 69 | Infantile muscular hypotonia (HP:0008947) | 2.44483843 |
| 70 | Ileus (HP:0002595) | 2.44236292 |
| 71 | Vascular calcification (HP:0004934) | 2.42213076 |
| 72 | Lipoatrophy (HP:0100578) | 2.41026964 |
| 73 | Abnormal cartilage morphology (HP:0002763) | 2.40218531 |
| 74 | Abnormality of the labia (HP:0000058) | 2.39794721 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.37032805 |
| 76 | Pancreatitis (HP:0001733) | 2.36941137 |
| 77 | Opisthotonus (HP:0002179) | 2.36022299 |
| 78 | Conjugated hyperbilirubinemia (HP:0002908) | 2.34613938 |
| 79 | Persistence of primary teeth (HP:0006335) | 2.34587566 |
| 80 | Focal segmental glomerulosclerosis (HP:0000097) | 2.33215402 |
| 81 | Aortic dissection (HP:0002647) | 2.27467884 |
| 82 | Curly hair (HP:0002212) | 2.26543443 |
| 83 | Esophageal varix (HP:0002040) | 2.25986969 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.25425660 |
| 85 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.23044872 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22499293 |
| 87 | Polycythemia (HP:0001901) | 2.19966111 |
| 88 | Sudden cardiac death (HP:0001645) | 2.17766505 |
| 89 | Resting tremor (HP:0002322) | 2.16729635 |
| 90 | Abdominal distention (HP:0003270) | 2.13787524 |
| 91 | Hyperpituitarism (HP:0010514) | 2.12095854 |
| 92 | Fragile nails (HP:0001808) | 2.10731277 |
| 93 | Difficulty walking (HP:0002355) | 2.07144394 |
| 94 | Stridor (HP:0010307) | 2.06977449 |
| 95 | Cupped ribs (HP:0000887) | 2.06668616 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 2.05998457 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04803189 |
| 98 | Milia (HP:0001056) | 2.03149896 |
| 99 | Pustule (HP:0200039) | 2.01588792 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 2.01304221 |
| 101 | Achilles tendon contracture (HP:0001771) | 2.00573712 |
| 102 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00486663 |
| 103 | Right ventricular cardiomyopathy (HP:0011663) | 10.3556875 |
| 104 | Abnormality of the clitoris (HP:0000056) | 1.99743770 |
| 105 | Ankyloglossia (HP:0010296) | 1.99670947 |
| 106 | Premature rupture of membranes (HP:0001788) | 1.98892486 |
| 107 | Fasciculations (HP:0002380) | 1.98853701 |
| 108 | Generalized hypopigmentation of hair (HP:0011358) | 1.94507046 |
| 109 | Onycholysis (HP:0001806) | 1.93976513 |
| 110 | Restlessness (HP:0000711) | 1.93940188 |
| 111 | Ketoacidosis (HP:0001993) | 1.93754213 |
| 112 | Hypoglycemic coma (HP:0001325) | 1.92689631 |
| 113 | Growth hormone excess (HP:0000845) | 1.89168336 |
| 114 | Xanthomatosis (HP:0000991) | 1.88953331 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.88311442 |
| 116 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.87876410 |
| 117 | Polygenic inheritance (HP:0010982) | 1.87291828 |
| 118 | Hypoalphalipoproteinemia (HP:0003233) | 1.87065875 |
| 119 | Hypercortisolism (HP:0001578) | 1.86395129 |
| 120 | Cerebral aneurysm (HP:0004944) | 1.84447119 |
| 121 | Hypercholesterolemia (HP:0003124) | 1.84390676 |
| 122 | Conjunctival hamartoma (HP:0100780) | 1.80165205 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.80162391 |
| 124 | Broad metatarsal (HP:0001783) | 1.79636610 |
| 125 | Seborrheic dermatitis (HP:0001051) | 1.79404563 |
| 126 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.79147345 |
| 127 | Vertebral hypoplasia (HP:0008417) | 1.79147345 |
| 128 | Limb hypertonia (HP:0002509) | 1.78802636 |
| 129 | Lethargy (HP:0001254) | 1.78705447 |
| 130 | Choanal stenosis (HP:0000452) | 1.78466719 |
| 131 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.78097584 |
| 132 | Hyperammonemia (HP:0001987) | 1.77180475 |
| 133 | Ketosis (HP:0001946) | 1.77109256 |
| 134 | Precocious puberty (HP:0000826) | 1.76288708 |
| 135 | Hyperglycemia (HP:0003074) | 1.75370547 |
| 136 | Renal salt wasting (HP:0000127) | 1.75047877 |
| 137 | Pili torti (HP:0003777) | 1.74599237 |
| 138 | Glomerulopathy (HP:0100820) | 1.74542886 |
| 139 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.73732128 |
| 140 | Testicular neoplasm (HP:0010788) | 1.72153988 |
| 141 | Visceral angiomatosis (HP:0100761) | 1.71971547 |
| 142 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71032932 |
| 143 | Shallow orbits (HP:0000586) | 1.70536255 |
| 144 | Plantar hyperkeratosis (HP:0007556) | 1.69615780 |
| 145 | Metaphyseal cupping (HP:0003021) | 1.68696871 |
| 146 | Subcapsular cataract (HP:0000523) | 1.68493614 |
| 147 | Abnormality of serum amino acid levels (HP:0003112) | 1.68133261 |
| 148 | Fragile skin (HP:0001030) | 1.67675821 |
| 149 | Aortic aneurysm (HP:0004942) | 1.66969721 |
| 150 | Aneurysm (HP:0002617) | 1.66770495 |
| 151 | Spastic tetraparesis (HP:0001285) | 1.66503030 |
| 152 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66263864 |
| 153 | Myokymia (HP:0002411) | 1.66210308 |
| 154 | Abnormality of the 1st metacarpal (HP:0010009) | 1.66178178 |
| 155 | Abnormality of the peritoneum (HP:0002585) | 1.66100578 |
| 156 | Turricephaly (HP:0000262) | 1.65920731 |
| 157 | Abnormality of the fingertips (HP:0001211) | 1.65623144 |
| 158 | Ectopia lentis (HP:0001083) | 1.64898353 |
| 159 | Spinal rigidity (HP:0003306) | 1.63793437 |
| 160 | Cone-rod dystrophy (HP:0000548) | 1.63784044 |
| 161 | Polar cataract (HP:0010696) | 1.62953233 |
| 162 | Dicarboxylic aciduria (HP:0003215) | 1.62939683 |
| 163 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.62939683 |
| 164 | Mutism (HP:0002300) | 1.62533152 |
| 165 | Spinal cord compression (HP:0002176) | 1.62386476 |
| 166 | Periodontitis (HP:0000704) | 1.61026392 |
| 167 | Amyloidosis (HP:0011034) | 1.60815671 |
| 168 | Glomerulonephritis (HP:0000099) | 1.58447877 |
| 169 | Rapidly progressive (HP:0003678) | 1.58154249 |
| 170 | Joint hemorrhage (HP:0005261) | 1.58126451 |
| 171 | Congenital, generalized hypertrichosis (HP:0004540) | 1.58058031 |
| 172 | Microretrognathia (HP:0000308) | 1.57985004 |
| 173 | Long toe (HP:0010511) | 1.57832816 |
| 174 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.57435176 |
| 175 | Tubulointerstitial fibrosis (HP:0005576) | 1.57182646 |
| 176 | Sudden death (HP:0001699) | 1.56759161 |
| 177 | Neonatal hypoglycemia (HP:0001998) | 1.56755474 |
| 178 | Hemangiomatosis (HP:0007461) | 1.56381472 |
| 179 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.56324189 |
| 180 | Abnormality of carpal bone ossification (HP:0006257) | 1.55737387 |
| 181 | Short nail (HP:0001799) | 1.54991050 |
| 182 | Macroglossia (HP:0000158) | 1.52294505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.26270910 |
| 2 | MST1R | 3.84188922 |
| 3 | SIK1 | 3.36594070 |
| 4 | MAP3K6 | 3.35621703 |
| 5 | TIE1 | 2.97306106 |
| 6 | TGFBR2 | 2.64059408 |
| 7 | EPHA3 | 2.62988870 |
| 8 | CAMK1 | 2.08703057 |
| 9 | CAMK1D | 2.07540091 |
| 10 | MAPK4 | 2.05043352 |
| 11 | ERBB4 | 13.9666213 |
| 12 | TRIB3 | 1.93027537 |
| 13 | ABL2 | 1.86444433 |
| 14 | PKN2 | 1.83626740 |
| 15 | PRKAA1 | 1.83417964 |
| 16 | PIM2 | 1.73922311 |
| 17 | LRRK2 | 1.59783262 |
| 18 | ADRBK1 | 1.54343038 |
| 19 | MET | 1.54147911 |
| 20 | MAP3K9 | 1.51266899 |
| 21 | KSR2 | 1.47540522 |
| 22 | RIPK4 | 1.37210400 |
| 23 | CDK6 | 1.34703530 |
| 24 | MAP3K2 | 1.34429111 |
| 25 | CAMKK2 | 1.26778084 |
| 26 | GSK3A | 1.22628154 |
| 27 | MAP2K2 | 1.21987662 |
| 28 | MAPK15 | 1.19820179 |
| 29 | PRKACG | 1.15590814 |
| 30 | FER | 1.15338922 |
| 31 | TAOK2 | 1.15307106 |
| 32 | MAP2K1 | 1.14940329 |
| 33 | PIK3CG | 1.14605405 |
| 34 | NLK | 1.10851442 |
| 35 | CAMK1G | 1.10356637 |
| 36 | STK10 | 1.10319176 |
| 37 | IRAK1 | 1.09239771 |
| 38 | CLK1 | 1.07709764 |
| 39 | LATS2 | 1.06654919 |
| 40 | PTK6 | 0.99474521 |
| 41 | PRKG2 | 0.96279540 |
| 42 | CDK9 | 0.96139959 |
| 43 | LMTK2 | 0.94645020 |
| 44 | MTOR | 0.92129955 |
| 45 | RIPK1 | 0.89257579 |
| 46 | MAPK12 | 0.86930701 |
| 47 | FRK | 0.85006142 |
| 48 | ERN1 | 0.83184132 |
| 49 | FYN | 0.82396021 |
| 50 | NUAK1 | 0.82209105 |
| 51 | GRK1 | 0.80865215 |
| 52 | MOS | 0.79582709 |
| 53 | PAK3 | 0.79465065 |
| 54 | PRKCI | 0.78369093 |
| 55 | MAP2K3 | 0.77154266 |
| 56 | IRAK3 | 0.74487533 |
| 57 | PRPF4B | 0.73197534 |
| 58 | IKBKB | 0.72748831 |
| 59 | STK39 | 0.72115991 |
| 60 | NEK1 | 0.71468143 |
| 61 | NME1 | 0.71427106 |
| 62 | TAOK1 | 0.71365045 |
| 63 | PAK2 | 0.70862696 |
| 64 | JAK3 | 0.70570910 |
| 65 | TESK1 | 0.67544713 |
| 66 | FGFR4 | 0.66859763 |
| 67 | GRK5 | 0.64806620 |
| 68 | BCKDK | 0.63223670 |
| 69 | DDR2 | 0.62607056 |
| 70 | PDGFRB | 0.62470374 |
| 71 | NME2 | 0.61758428 |
| 72 | MAPK3 | 0.61401109 |
| 73 | WNK4 | 0.59957418 |
| 74 | ICK | 0.58857176 |
| 75 | BMPR2 | 0.56068120 |
| 76 | PAK4 | 0.55826521 |
| 77 | MAPK7 | 0.55683416 |
| 78 | ROCK2 | 0.55352178 |
| 79 | PDK4 | 0.54265250 |
| 80 | PDK3 | 0.54265250 |
| 81 | BMX | 0.53890537 |
| 82 | WNK1 | 0.53113150 |
| 83 | MAP3K8 | 0.52763112 |
| 84 | MAPK1 | 0.50482596 |
| 85 | MYLK | 0.49681432 |
| 86 | PRKACB | 0.49667704 |
| 87 | SRC | 0.49452515 |
| 88 | MAPKAPK3 | 0.49438478 |
| 89 | FLT3 | 0.48555098 |
| 90 | EEF2K | 0.48427762 |
| 91 | CDK4 | 0.47868355 |
| 92 | PTK2 | 0.47168746 |
| 93 | RPS6KB2 | 0.45131199 |
| 94 | ERBB2 | 0.44431940 |
| 95 | EPHB1 | 0.43655246 |
| 96 | JAK1 | 0.42687252 |
| 97 | MAP3K10 | 0.40883183 |
| 98 | PDPK1 | 0.39204612 |
| 99 | RET | 0.39180929 |
| 100 | MAP3K3 | 0.39035496 |
| 101 | ZAP70 | 0.38908925 |
| 102 | CHUK | 0.38882854 |
| 103 | PIM1 | 0.37708961 |
| 104 | RPS6KA5 | 0.36589468 |
| 105 | IGF1R | 0.36497195 |
| 106 | MAP2K4 | 0.36157061 |
| 107 | INSR | 0.35229672 |
| 108 | PRKG1 | 0.35152798 |
| 109 | MAP3K1 | 0.34028461 |
| 110 | RPS6KA2 | 0.33714102 |
| 111 | STK3 | 0.33412614 |
| 112 | FES | 0.33306791 |
| 113 | MATK | 0.32898736 |
| 114 | MAP3K5 | 0.30571325 |
| 115 | ROCK1 | 0.30241645 |
| 116 | GRK6 | 0.30113529 |
| 117 | CAMKK1 | 0.29930252 |
| 118 | ARAF | 0.29390279 |
| 119 | TYRO3 | 0.29146305 |
| 120 | CSK | 0.28904605 |
| 121 | LIMK1 | 0.28563220 |
| 122 | CDK19 | 0.28035519 |
| 123 | MELK | 0.27888870 |
| 124 | PDK1 | 0.27745973 |
| 125 | CAMK2B | 0.27568050 |
| 126 | RPS6KL1 | 0.26926276 |
| 127 | RPS6KC1 | 0.26926276 |
| 128 | DMPK | 0.26568498 |
| 129 | PDK2 | 0.25856296 |
| 130 | ALK | 0.25553774 |
| 131 | MAP3K11 | 0.24753772 |
| 132 | MINK1 | 0.24081383 |
| 133 | PDGFRA | 0.22820635 |
| 134 | NTRK1 | 0.22167914 |
| 135 | TTN | 0.21933093 |
| 136 | CAMK2D | 0.21662477 |
| 137 | EGFR | 0.21270263 |
| 138 | MAP3K13 | 0.20183192 |
| 139 | PRKD1 | 0.19434358 |
| 140 | FGR | 0.18835180 |
| 141 | CAMK2G | 0.18384899 |
| 142 | KSR1 | 0.17871982 |
| 143 | KDR | 0.16311368 |
| 144 | PRKCQ | 0.15672802 |
| 145 | EPHB2 | 0.14796895 |
| 146 | SCYL2 | 0.13217867 |
| 147 | CDK5 | 0.11953840 |
| 148 | ILK | 0.11010573 |
| 149 | PRKAA2 | 0.10930847 |
| 150 | PAK1 | 0.10800939 |
| 151 | DAPK3 | 0.10685953 |
| 152 | PHKG2 | 0.10627330 |
| 153 | PHKG1 | 0.10627330 |
| 154 | PAK6 | 0.10545837 |
| 155 | MAP3K7 | 0.10322861 |
| 156 | JAK2 | 0.09990094 |
| 157 | RPS6KA1 | 0.09462789 |
| 158 | RAF1 | 0.09169368 |
| 159 | TBK1 | 0.09074186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 6.37897039 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.52999362 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.05812884 |
| 4 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 5.04052880 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 4.62815446 |
| 6 | Gastric acid secretion_Homo sapiens_hsa04971 | 4.52148159 |
| 7 | Protein digestion and absorption_Homo sapiens_hsa04974 | 4.44810437 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.43249524 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.90549076 |
| 10 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.63574608 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.20629611 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.00423848 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.12457794 |
| 14 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.00015215 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.87813183 |
| 16 | Mineral absorption_Homo sapiens_hsa04978 | 1.53929534 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49529680 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47131921 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.40351997 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33173218 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28649428 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23662400 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22658698 |
| 24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20569343 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17550874 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16480705 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15506583 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15159518 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12942626 |
| 30 | Insulin resistance_Homo sapiens_hsa04931 | 1.05308527 |
| 31 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.02137004 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00621521 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96231621 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95613035 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94800928 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90464366 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86697062 |
| 38 | Malaria_Homo sapiens_hsa05144 | 0.86548006 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85569309 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 0.81842592 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80989849 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80421529 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76798465 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74718370 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73796174 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73343336 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72926281 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72081053 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67207036 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65546336 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.63890789 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63729862 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63551889 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62309790 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60807413 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60644009 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60635371 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60600125 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60138235 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59736875 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58216088 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55930299 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55827022 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55700260 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55696614 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54670873 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54255484 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53981232 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53838709 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53451140 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52293454 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51760126 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48559130 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46572640 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44913419 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43534340 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43460712 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41927588 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39846039 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.39002339 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38858413 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38523628 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37538631 |
| 84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37032839 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36470994 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34859574 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31560347 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30689555 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30110231 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29947033 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.29740029 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29688686 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29089339 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27416443 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.27158892 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.25727189 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.25434795 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.25270028 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25146671 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24978454 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.24360057 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.23792809 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23668538 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.23047542 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22610600 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21918649 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21575916 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20117146 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.19986657 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.18595057 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18492210 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.17967477 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.16765855 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.16246066 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15684511 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.14877131 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.14551015 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.14508527 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.14424083 |
| 120 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.14330690 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14047628 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.13941212 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.12780076 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12607300 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.12444599 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12339845 |
| 127 | Long-term potentiation_Homo sapiens_hsa04720 | 0.12210286 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11931136 |
| 129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.11574899 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.11548439 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.11350593 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10690109 |
| 133 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.10686056 |
| 134 | Insulin secretion_Homo sapiens_hsa04911 | 0.10431093 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.08746369 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.08617294 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08566940 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.08153291 |
| 139 | Cocaine addiction_Homo sapiens_hsa05030 | 0.07959081 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07370991 |
| 141 | HTLV-I infection_Homo sapiens_hsa05166 | 0.06338092 |
| 142 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.04791903 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.04737454 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.03928637 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.01809912 |
| 146 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.01280106 |
| 147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00511825 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.00415351 |
| 149 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0029611 |

